Autoantibody:Autoantigen Competitor Decoys: Application to Cardiac Phenotypes.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 10 11 2021
accepted: 12 01 2022
entrez: 14 2 2022
pubmed: 15 2 2022
medline: 29 3 2022
Statut: epublish

Résumé

Autoimmune diseases are often associated with autoantibodies that abnormally target self-antigens (autoantigens). An intuitive therapeutic strategy for diseases caused by aAbs is to design decoys, or soluble molecules that target the antigen combining site of these aAbs, thereby blocking binding of aAb to self-antigen and subsequent tissue damage. Here, we review the known decoy molecules of these types, discuss newer technological opportunities afforded by monoclonal antibody and structural biology advances, and discuss the challenges to this approach. Recent opportunities relevant to this approach for cardiac phenotypes, specifically Ro-associated long QT syndrome, are discussed.

Identifiants

pubmed: 35154130
doi: 10.3389/fimmu.2022.812649
pmc: PMC8832015
doi:

Substances chimiques

Antibodies, Monoclonal 0
Autoantibodies 0
Autoantigens 0

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

812649

Informations de copyright

Copyright © 2022 Cardozo, Cardozo and Boutjdir.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Front Cardiovasc Med. 2019 Dec 03;6:181
pubmed: 31850376
Cell. 2005 May 20;121(4):529-539
pubmed: 15907467
J Am Heart Assoc. 2021 Feb 16;10(4):e018735
pubmed: 33533258
J Mol Endocrinol. 2011 Feb 15;46(2):81-99
pubmed: 21247981
Circ Arrhythm Electrophysiol. 2016 Apr;9(4):e003419
pubmed: 27030700
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Biomaterials. 2016 Dec;111:116-123
pubmed: 27728811
Arthritis Rheum. 2010 May;62(5):1448-56
pubmed: 20131295
Cell. 2016 Jun 30;166(1):88-101
pubmed: 27293190
Biochem Biophys Res Commun. 2002 Jan 18;290(2):656-62
pubmed: 11785949
Lupus. 2012 May;21(6):586-95
pubmed: 22300829
Nature. 2021 Aug;596(7873):590-596
pubmed: 34293799
Hypertension. 2015 Apr;65(4):793-9
pubmed: 25691619
JAMA. 2003 Apr 23-30;289(16):2041-4
pubmed: 12709446
Circulation. 2015 Jul 28;132(4):230-40
pubmed: 25995318
J Am Coll Cardiol. 2007 Oct 30;50(18):1808-9
pubmed: 17964047
Nat Struct Biol. 1997 May;4(5):374-81
pubmed: 9145108
Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1955-60
pubmed: 9050886
J Immunol. 2012 Jun 1;188(11):5792-9
pubmed: 22523387
Drug Discov Today. 2015 Oct;20(10):1271-83
pubmed: 26360055
Biochemistry. 2007 Dec 25;46(51):14987-95
pubmed: 18052043
J Thromb Haemost. 2009 May;7(5):833-42
pubmed: 19220729
J Immunol. 2006 Feb 1;176(3):1525-33
pubmed: 16424181
Nucleic Acids Res. 2017 Jan 4;45(D1):D769-D776
pubmed: 27924021
Autoimmun Rev. 2006 Jul;5(6):367-72
pubmed: 16890888
J Exp Med. 2014 Mar 10;211(3):405-11
pubmed: 24534192
Trends Cardiovasc Med. 2000 Apr;10(3):114-22
pubmed: 11427998
Arch Pathol Lab Med. 2000 Jan;124(1):71-81
pubmed: 10629135
Arthritis Res Ther. 2020 May 24;22(1):120
pubmed: 32448385
J Autoimmun. 2010 Mar;34(2):80-6
pubmed: 19640679
Nat Biotechnol. 1997 Jan;15(1):41-5
pubmed: 9035104
Circulation. 2010 Mar 2;121(8):1047-60
pubmed: 20142454
J Am Coll Cardiol. 2020 May 5;75(17):2153-2155
pubmed: 32354383
Curr Opin Cardiol. 2003 Jan;18(1):6-13
pubmed: 12496496
Nat Rev Immunol. 2019 Jan;19(1):63-64
pubmed: 30552387
Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2355-9
pubmed: 7534420
J Physiol. 2016 Nov 1;594(21):6175-6187
pubmed: 27296897
Scand J Immunol. 2010 Sep;72(3):226-34
pubmed: 20696020
Thyroid. 2019 Jul;29(7):1012-1017
pubmed: 31062662
J Biol Chem. 2018 May 4;293(18):7008-7016
pubmed: 29523691
J Med Chem. 2016 Oct 13;59(19):8859-8867
pubmed: 27603688
Arthritis Rheum. 2011 Dec;63(12):3740-8
pubmed: 22127694
Clin Immunol. 2013 Jul;148(1):27-34
pubmed: 23644453
Card Electrophysiol Clin. 2016 Jun;8(2):373-84
pubmed: 27261828

Auteurs

Timothy Cardozo (T)

Department of Biochemistry and Molecular Pharmacology, New York University (NYU) Grossman School of Medicine, New York, NY, United States.

Lila Cardozo (L)

Department of Biochemistry and Molecular Pharmacology, New York University (NYU) Grossman School of Medicine, New York, NY, United States.

Mohamed Boutjdir (M)

Department of Medicine, New York University (NYU) Grossman School of Medicine, New York, NY, United States.
Department of Medicine, Cell Biology and Pharmacology, State University of New York Downstate Medical Center, New York, NY, United States.
Cardiovascular Research Program, VA New York Harbor Healthcare System, New York, NY, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH